Kura Oncology
KURA
19 hedge funds and large institutions have $41.4M invested in Kura Oncology in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 2 closing their positions.
300% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 2
36% more funds holding
Funds holding: 14 → 19 (+5)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
52% less capital invested
Capital invested by funds: $86.1M → $41.4M (-$44.7M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$325K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$299K |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$227K |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
+$111K |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$72.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$1.14M |
| 2 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$309K |
| 3 |
PIM
Partner Investment Management
San Francisco,
California
|
-$136K |
| 4 |
BC
Birchview Capital
Burlington,
Vermont
|
-$124K |
| 5 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$95.4K |
KURA Hedge Fund Activity: Q1 2016 in Review
19 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q1 2016, worth a combined $41.4M — down 52% from $86.1M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new KURA positions and 2 closed out — a net gain of 6 holders — while 5 added to existing stakes and 6 trimmed.
The largest buyer was Vanguard Group, adding an estimated $325K. The largest seller was Franklin Resources, cutting an estimated $1.14M.
- 19 institutional investors held Kura Oncology (KURA) as of Q1 2016, up from 14 in Q4 2015.
- Funds reported $41.4M of Kura Oncology stock for Q1 2016, down 52% quarter-over-quarter.
- 8 funds opened new Kura Oncology positions in Q1 2016 and 2 closed out, a net change of +6 holders.
- The largest Kura Oncology buyer in Q1 2016 was Vanguard Group, an estimated $325K added.
- The largest Kura Oncology seller in Q1 2016 was Franklin Resources, an estimated $1.14M sold.
Based on aggregated 13F filings for Q1 2016.